Anatomic Stage IV Breast Cancer AJCC
1 clinical trials · Condition
◉ Watch Anatomic Stage IV Breast Cancer AJCC
| Record | Firm | Date |
|---|---|---|
| Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer (NCT03599453) | Roswell Park Cancer Institute | 2019-01-09 |
Track Anatomic Stage IV Breast Cancer AJCC automatically
Every clearance here is in the API, with alerts when new ones post.